CheckMyRecalls

PFIZER INC recalls Vial Label

Published
27 Aug 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10.

Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14.

Brand / company
PFIZER INC
Codes / lots
Lot #: LY3681, LY4360, LY4416, Exp. 02/28/2026 | Lot #: LH2671, Exp. 11/30/2026
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 27 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.